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ABSTRACT 
 
Background Papillon-Lefévre (PLS; OMIM 245000) and Haim-Munk syndromes (HMS; 
OMIM 245010) are phenotypic variants of the same rare disease caused by mutations of the 
cathepsin C (CTSC) gene and exhibit autosomal recessive inheritance. 
Aims To identified the diseases causes mutations of the CTSC gene in the case of the patients 
and to perform haplotype analysis to elucidate that any familial relationship between the two 
investigated patients. 
Methods Mutations were identified by direct sequencing of genomic DNA amplified for 
exonic regions of CTSC gene and haplotype analysis was performed. 
Results Mutation screening of the CTSC gene from two Hungarian patients revealed the 
presence of the same heterozygous nonsense mutation (c.748C/T; p.Arg250X). However, one 
patient exhibited the PLS phenotype and the other the HMS phenotype. Although these 
patients were not aware that they were related, haplotype analysis revealed that they carry the 
same haplotype, and the possibility that they are related cannot be excluded.  
Conclusions Our results support the hypothesis that PLS and HMS are the phenotypic 
variants of the same disease and, additionally, exclude the presence of a putative genetic 
modifier factor within the CTSC gene that is responsible for the development of the two 
phenotypes. We hypothesize that this putative genetic modifier factor is located outside the 
CTSC gene or, alternatively, that the development of the different phenotypes is the 
consequence of different environmental or life style factors.  
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INTRODUCTION  
 
Papillon-Lefévre (PLS; OMIM 245000) and Haim-Munk syndromes (HMS; OMIM 245010) 
are phenotypic variants of the same disease. PLS and HMS are characterized by overlapping 
dermatological and dental symptoms such as hyperkeratosis of the palms and soles as well as 
severe periodontitis.1,2 Patients with PLS can also develop mild mental retardation, 
calcification of the dura mater, hyperhidrosis and increased susceptibility to infections.3,4,5 
Specific features of HMS include pes planus, arachnodactyly, acroosteolysis and 
onychogryphosis.6,7,8 The prevalence of PLS is approximately four cases per million, and, to 
date, approximately 300 cases have been reported worldwide. Parental consanguinity has been 
noted in more than 50% of these cases.4,9 The prevalence of HMS is approximately one case 
per million, and the majority of reported cases are descendants of a few consanguineous 
families from a religious isolate in Cochin, India. One unrelated Brazilian patient has also 
been reported. Fewer than 100 HMS cases have been reported in the literature to date.6,7, 8 The 
ratio of affected males to females is 1:1 for both phenotypic variants. PLS and HMS are both 
inherited in an autosomal recessive manner and develop as a consequence of mutations of the 
cathepsin C (CTSC) gene.10,11 Currently, 75 CTSC gene mutations have been identified.1 The 
majority of these mutations (74 of 75, 99%), have been detected in PLS patients, whereas 
only 4% (three of 75), have been associated with HMS.1,2,7,8 Two mutations (c.145C/T, 
p.Gln49X and c.857A/G p.Gln286Arg) were present in patients exhibiting both PLS and 
HMS phenotypes. Only one mutation (c.587T/C p.Leu196Pro) has been associated 
exclusively with HMS.2,8,12,13 
Here we report two Hungarian patients affected by different phenotypic variants, one with 
PLS and one with HMS, who nonetheless carry the same homozygous nonsense mutation 
(c.748C/T; p.Arg250X) of the CTSC gene. Polymorphisms surrounding the mutation were 
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investigated to determine whether these patients are relatives and to possibly identify a 
genetic modifier factor within the CTSC gene, which could be responsible for the 
development of the different phenotypes.  
 
MATERIALS AND METHODS 
Patients 
Both patients were referred to the out-patient clinic of the Mór Kaposi Teaching Hospital 
(Kaposvár; Hungary). 
A 39-year-old Hungarian woman (Patient I) presented with a typical HMS phenotype. Mild 
hyperkeratotic plaques were observed symmetrically on her palms (Fig. 1a) and soles (Fig. 
1c). Onychogryphosis and arachnodactyly were noted on her fingers (Fig. 1b) and pes planus 
on her soles (Fig. 1b). The patient lost all permanent teeth and uses a permanent dental 
prosthesis. She was brought up in state care without knowing her parents and has no husband 
or child. She was not aware of any known relatives. 
A 25-year-old Hungarian man (Patient II) presented with the classical PLS phenotype. The 
hyperkeratosis on his palms (Fig. 1d) and soles (Fig. 1e) was more severe than the symptoms 
of Patient I. Onychogryphosis, arachnodactyly and pes planus were not present. He was also 
missing all permanent teeth and using a permanent dental prosthesis. His parents and his wife 
were clinically unaffected. He had no siblings or children. He was not aware of any family 
members that are clinically affected (Fig. 1f). 
 
Genetic investigation 
Blood samples were taken from the two investigated patients and from unrelated controls for 
genetic investigation. Genomic DNA was isolated with a BioRobot EZ1 DSP Workstation 
(QIAGEN; Godollo, Hungary). After amplifying the coding regions and flanking introns of 
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the CTSC gene (using primer sequences displayed on the UCSC Genome Browser, 
http://www.genome.ucsc.edu), DNA sequencing was performed on amplification products. 
Sequencing data was analyzed to screen for any additional mutations and to genotype all the 
common polymorphisms of the CTSC gene. Based on the polymorphism data, haplotype 
analysis was performed to elucidate any familial relationship between the two investigated 
patients. The polymorphism data were compared in an attempt to identify a putative genetic 
modifier variant within the CTSC gene that could be responsible for the observed differences 
in the phenotypes of the patients. 
Written informed consent was obtained from all investigated individuals, and the study was 
conducted according to the Principles of the Declaration of Helsinki.  
 
RESULTS 
 
Direct sequencing of the coding regions of the CTSC gene from Patient I and Patient II 
revealed a nonsense mutation in the fifth exon (c.748C/T, p.Arg250X). The patients carried 
the mutation in homozygous form (Fig. 2a), while the unrelated controls carried the wild type 
sequence (Fig. 2b).  
The presence of the same homozygous nonsense mutation in both patients raised the 
possibility of familial relationship between them. To address this, the polymorphisms located 
in the 3' and 5' regions of the identified mutation were genotyped and the haplotypes were 
determined. The patients were homozygous for all the genotyped polymorphisms, and all 
genotypes were the same for both patients, indicating they carried exactly the same haplotype 
(Table I).  
Since the patients presented different phenotypes (i.e., HMS and PLS), but carried the same 
homozygous nonsense mutation, further screening was performed to identify a putative 
Page 6 of 18Clinical and Experimental Dermatology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
7 
 
second genetic modifier variant within the CTSC gene. A comparison of all polymorphism 
and genotypes of the coding regions and flanking introns of the CTSC gene did not reveal any 
genetic difference between the two patients: they both carried exactly the same genotypes 
regarding all the investigated polymorphisms (Table I).  
 
DISCUSSION  
 
Currently, 75 different mutations have been reported worldwide for the CTSC gene.1 
Nonsense mutations, accounting for 23% (n=17) of pathogenic CTSC mutations, occur in all 
coding regions of the gene; however the majority is located in exons 5–7, which encodes the 
heavy chain region of the cathepsin C protein.1,14 This protein is a lysosomal cysteine 
protease, and the heavy chain region is important for enzyme activity.14,15 The p.Arg250X 
homozygous nonsense mutation detected in the investigated patients is also located in this 
region. The p.Arg250X mutation leads to the formation of a truncated protein and may 
significantly impair enzyme activity. This hypothesis correlates well with previous studies 
demonstrating that pathological changes in the CTSC gene are loss-of-function mutations 
resulting in the inactivation of enzymatic activity and altered regulation of the immune 
response, which increase the susceptibility tp periodontal inflammation and skin 
infections.16,17  
The p.Arg250X nonsense mutation has already been previously reported in patients with 
PLS;18,19 however, this is the first report of its association with HMS. The mutation has been 
previously detected in homozygous18 and in compound heterozygous forms.19 The latter 
mutation was suggested to be associated with an unidentified heterozygous mutation of the 
CTSC gene.19 A previous investigation detected this mutation in homozygous form in Turkish 
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patients.18 It is likely that these Turkish and Hungarian PLS patients have a common 
haplotype (Table I) and the identified mutation is the consequence of a single founder effect. 
The two investigated Hungarian patients were affected by different variants (PLS and HMS) 
of the phenotypic spectrum caused by CTSC mutations. Clinical differences between the PLS 
and HMS symptoms of the patients were striking, although, surprisingly, genetic screening 
identified the presence of the same nonsense mutation (p.Arg250X) in homozygous form in 
both patients. Haplotype analysis revealed that the two patients exhibit the same haplotype 
(Table I), indicating a strong likelihood of relatedness. The patients were not aware of any 
such relationship. Patient I was brought up in state care and did not know any of her relatives. 
Patient II was not aware of consanguinity within his family. However, our results and the fact 
that they share a common family name strongly suggest familial relationship between the two 
investigated patients.  
As the patients had the same homozygous disease-causing mutation as well as the same 
haplotype, it was possible to examine genetic variations in the CTSC gene to identify any 
differences that could account for the development of the phenotypic differences. Our 
investigation could not identify any such genetic variant with the CTSC gene and flanking 
regions. Therefore, we hypothesize that the putative modifier factor, which results in the 
development of different phenotypic variants for this CTSC mutation, is not located in the 
region of CTSC, but in another region. Moreover, we cannot exclude the possibility that the 
reason for the phenotypic variation is a non-genetic influence, such as environmental or life 
style factors. 
Our results further support the accepted viewpoint that PLS and HMS are not different disease 
entities, but that they are phenotypic variants of the same disease and their development is 
influenced by other factors. This phenomenon has also been observed in another group of rare 
monogenic diseases caused by mutations in the CYLD gene. Initially, Brooke-Spiegler 
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syndrome (BSS; OMIM 605041), multiple familial trichoepithelioma type 1 (MFT1; OMIM 
601606) and familial cylindromatosis (FC; OMIM 132700) were considered different entities, 
until genetic investigation revealed that they were allelic variants of the same disease.20,21  
These observations highlight the importance of genetic investigation and the establishment of 
genotype–phenotype associations. 
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FIGURE LEGENDS 
 
Figure 1. Skin symptoms of two Hungarian patients. Patient I, presenting with HMS, 
exhibited mild hyperkeratosis on her palms (a), onychogryphosis and arachnodactly of her 
fingers (b) and mild hyperkeratosis and pes planus on her soles (c). Patient II, presenting with 
PLS, was affected by moderate hyperkeratosis of his palms (d) and soles (f) and exhibited no 
specific symptoms of HMS. Patient I was brought up in state care without knowing her 
relatives. No other affected individuals are known in the family of Patient II (e). 
 
Figure 2. Mutation screening of the CTSC gene. Direct sequencing revealed a nonsense 
mutation (c.748C/T, p.Arg250STOP) in the fifth exon of the CTSC gene. Both Patient I and II 
carried the mutation in homozygous form (a), while all the unrelated healthy control 
individuals carried the wild type sequence (b). 
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Table I. Haplotype analysis. Patient I and II exhibited the same haplotype. 
Polymorphisms  Common 
allele 
Patient I. Patient II. 
rs116702910 T TT TT 
rs77499989 A AA AA 
rs144951351 T TT TT 
rs150778155 GAAA GAAA GAAA 
rs60736750 C CC CC 
rs150294063 T TT TT 
rs186157569 A AA AA 
rs112016678 C CC CC 
rs147642061 T TT TT 
CM002938* C TT TT 
rs200799436 T TT TT 
rs217116 T TT TT 
rs141174591 G GG GG 
rs115099408 C CC CC 
rs147844154 G GG GG 
rs217115 A AA AA 
rs74325198 T TT TT 
rs181513908 A AA AA 
rs188791825 G GG GG 
*The identified homozygous nonsense mutation (c.748C/T p.Arg250X) 
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Figure 1. Skin symptoms of two Hungarian patients. Patient I, presenting with HMS, exhibited mild 
hyperkeratosis on her palms (a), onychogryphosis and arachnodactly of her fingers (b) and mild 
hyperkeratosis and pes planus on her soles (c). Patient II, presenting with PLS, was affected by moderate 
hyperkeratosis of his palms (d) and soles (f) and exhibited no specific symptoms of HMS. Patient I was 
brought up in state care without knowing her relatives. No other affected individuals are known in the family 
of Patient II (e).  
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Figure 2. Mutation screening of the CTSC gene. Direct sequencing revealed a nonsense mutation (c.748C/T, 
p.Arg250STOP) in the fifth exon of the CTSC gene. Both Patient I and II carried the mutation in homozygous 
form (a), while all the unrelated healthy control individuals carried the wild type sequence (b).  
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